Evidence map›Paper›PMID 32962148›Full record

ArticleVaccines2020

Maria A De Francesco, Federico Alberici, Nicola Bossini, Francesco Scolari, Federico Pascucci, Gabriele Tomasoni, Arnaldo Caruso

Open access · goldAbstract readCase Reports
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Post-COVID-19 severeThe Journal of international medical research · 2025
    Review
  4. Trends in the Epidemiology ofJournal of fungi (Basel, Switzerland) · 2023
    Review
  5. Open forum infectious diseases · 2023
    Article
  6. Heliyon · 2023
    Article
  7. Article
  8. Concurrent Infection with SARS-CoV-2 andJournal of fungi (Basel, Switzerland) · 2022
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Detection ofJournal of fungi (Basel, Switzerland) · 2021
    Article
  17. Epidemiology of Systemic Mycoses in the COVID-19 Pandemic.Journal of fungi (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Maria A De FrancescoInstitute of Microbiology, Department of Molecular and Translational Medicine, University of Brescia-ASST Spedali Civili di Brescia, 25123 Brescia, Italy.ORCID 0000-0003-2221-6286
Federico AlbericiDepartment of Medical and Surgical Specialties, Radiologic Sciences and Public Health, University of Brescia, 25123 Brescia, Italy.ORCID 0000-0002-1686-5709
Nicola BossiniNephrology Unit, Spedali Civili Hospital, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Francesco ScolariDepartment of Medical and Surgical Specialties, Radiologic Sciences and Public Health, University of Brescia, 25123 Brescia, Italy.
Federico PascucciFirst Division of Anesthesiology and Intensive Care Unit, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Gabriele TomasoniFirst Division of Anesthesiology and Intensive Care Unit, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Arnaldo CarusoInstitute of Microbiology, Department of Molecular and Translational Medicine, University of Brescia-ASST Spedali Civili di Brescia, 25123 Brescia, Italy.ORCID 0000-0001-5178-566X
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 might potentially give rise to a more severe infection in solid organ transplant recipients due to their chronic immunosuppression. These patients are at a higher risk of developing concurrent or secondary bacterial and fungal infections. Co-infections can increase systemic inflammation influencing the prognosis and the severity of the disease, and can in turn lead to an increased need of mechanical ventilation, antibiotic therapy and to a higher mortality. Here we describe, for the first time in Europe, a fatal case of co-infection between SARS-CoV-2 and

Indexed as

COVID-19immunosuppressionpneumonia

Identifiers

PMID32962148
PMCPMC7565862
OpenAlexW3087618831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.